UBS AM’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
UBS AM's PPH Position: Q3 2026 in Review
UBS AM opened a new position in VanEck Pharmaceutical ETF (PPH) in Q3 2026: 136 shares worth $14.9K. The stake represents ﹤0.01% of the portfolio and ranks #3722 among its holdings.
154 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- UBS AM held 136 shares of VanEck Pharmaceutical ETF worth $14.9K as of Q3 2026.
- VanEck Pharmaceutical ETF was a new UBS AM position in Q3 2026.
- VanEck Pharmaceutical ETF made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3722 holding.
- 154 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.